Abbott India News

Abbott India Ltd witnessed a meteoric rise in its share prices, soaring over 9% to reach an all-time high on Friday, February 2. The surge was triggered by the pharmaceutical company's robust financial performance in the December quarter, highlighted by a ...

Large cap pharmaceuticals company, Abbott India on Friday announced a 9.5% YoY jump in net profit at Rs 231.4 crore for the fourth quarter ended March 31, 2023. Earlier last year, in the corresponding quarter, it announced a net profit of ...

Leading broking houses Motilal Oswal & Sharekhan has come up with a "Buy" recommendation on two midcap pharma stocks, namely Abbott India Ltd. and Ajanta Pharma Ltd. The brokerage claims a potential upside of up to 24% if you buy them ...

Sharekhan has given buy call to the bluechip pharmaceuticals stock Abbott India Ltd for a target price Rs 22,780 with a potential gain of 23.57%. The company reported double-digit revenue as well as strong earnings growth during these challenging times backed by agile business model leading to minimal disruptions.{photo-feature}...

ICICI Securities in a recent note said that the Indian market's rally is becoming broad-based for the first time since the financial year 2017, adding that 24 stocks have accounted for more than 75% of the BSE 100 performance in FY ...